Your World-Class Speaker Faculty

Take a closer look at the 120+ industry-renowned speakers who headlined the 16th World Clinical Biomarkers & Companion Diagnostics Summit.

Pharmaceutical Leaders
Technology & AI Innovators
Transformative Charities, Associations, Academics & Clinicians
Biotech Pioneers
Leading Precision Medicine Solution Providers

Pharmaceutical Leaders

Jeremy Ross

Senior Scientific Director & Senior Research Fellow, Precision Medicine, Oncology
AbbVie

Srinivas Venkatram

Director II, Companion Diagnostics Strategy Team Lead
AbbVie

Amy Gorman

International Precision Medicine & Diagnostics Commercial Leader
AbbVie

Danielle Townsley

Executive Director & Precision Medicine Therapeutic Area Head, Oncology
Amgen

Diarmuid Moran

Head of Precision Medicine & Diagnostics (R&D)
Astellas Pharma

John W. Longshore

Vice President, Scientific Affairs, Global Oncology Diagnostics
AstraZeneca

Etai Jacob

Executive Director, AI for Infectious Disease
AstraZeneca

Adriana Racolta

Senior Director, Global Regulatory Leader, IVD
Bayer

Jon Baden

Executive Director & Head, Precision Medicine
Bristol Myers Squibb

Jilian Golding

Global Commercial Strategy, Precision Medicine Lead
Bristol Myers Squibb

Sarah Hersey

Vice President & Head, Precision Medicine, Translational Sciences & Bioanalytical
Bristol Myers Squibb

Christina Bender

Director, Global Oncology Marketing, Biomarker Strategy
Daiichi Sankyo

Amy H. Kao

Senior Vice President, Global Head, Research Unit, & Neuroscience, Immunology & Billerica Campus Head
EMD Serono the Healthcare Business of Merck KGaA

Nancy Krunic

Vice President & Head, Precision Medicine
EMD Serono, the Healthcare Business of Merck KGaA

Stuart Bailey

Senior Vice President, Clinical Measurement Sciences
EMD Serono, the Healthcare Business of Merck KGaA

Zheng Feng

Head, Clinical Genomics, Clinical Measurements Sciences
EMD Serono, the Healthcare Business of Merck KGaA, Darmstadt, Germany

Lauri Diehl

Executive Director, Research Pathology
Gilead Sciences

Mike Washburn

Executive Director & Head, Integrative Sciences, Oncology Translational Medicine
GSK

Angela Silvestro

Director, Companion Diagnostics
GSK

Supriya Shah

Associate Director
Johnson & Johnson Innovative Medicine

David Weingeist

Scientific Director
Johnson & Johnson Innovative Medicine

Viraj Tyagi

Global Alliance Leader, Strategic Partnering, Precision Medicine & Diagnostics
Johnson & Johnson Innovative Medicine

Fernando Cruz-Guilloty

Director, Oncology Precision Medicine & Diagnostics
Johnson & Johnson Innovative Medicine

Andrea Stevens

Senior Director, Precision Medicine Access
Johnson & Johnson Innovative Medicine

Neha Kumar

Senior Director, Global Commercial Precision Medicine Strategy
Johnson & Johnson Innovative Medicine & Incoming Director-at-Large, National Society of Genetic Counselors

Neeraj Adya

Head, Diagnostics, Immunology
Johnson & Johnson Innovative Medicines

Jeffrey Emch

Associate Vice President, Precision Medicine
Merck

Carol Pena

Associate Vice President, Companion Diagnostic Development
Merck

Alexander Alschuler

Director, Global Regulatory Affairs
Merck

Said Francis

Chief Business Officer & General Manager, Individualized Neoantigen Therapies
Moderna

Karim Azer

Global Head, Data & AI, Clinical Development
Novartis

Ben Withey

Director, Commercial Diagnostics, CDx Lead
Pfizer

Sam Whitman

Director, Diagnostics Lifecycle Management
Pfizer

Wendy Valenius

Director, Global Regulatory Strategy, Companion Diagnostics
Pfizer

Jessica Falcon-Tedesco

Manager, Clinical Diagnostics
Regeneron

Brian Baker

Executive Director, Regulatory Affairs, In Vitro Diagnostics
Regeneron

Emanuele De Rinaldis

Vice President & Global Head, Target, Diseases & Systems Biology
Sanofi

Alina Ainbinder

Scientific Associate Director
Takeda

Partha Das

Global Medical Affairs Lead, Companion Diagnostics
Takeda

Christoph Menzel

Head, Companion Diagnostics & Biomarker Strategy
The Healthcare Business of Merck KGaA, Darmstadt, Germany

Technology & AI Innovators

Ashwini Ghogare

Life Science BD Leader, FrontierAI Startups
AWS

David Henderson

Customer Engineer III AI/ML, Life Sciences North
Google Cloud

Alexander Mehmet Ersoy

Director, Industry Advisory, Healthcare & Life Sciences
Microsoft

Tarun Mehra

Partner, Microsoft Health & Life Sciences
Microsoft

Transformative Charities, Associations, Academics & Clinicians

Lauren Leiman

Executive Director
BLOODPAC

Chris Fidyk

Executive Vice President, Business Development
Crohn’s & Colitis Foundation

Ilana Schlam

Breast Medical Oncologist
Dana-Farber Cancer Institute

Mark Stewart

Vice President, Science Policy
Friends of Cancer Research

Sizun Jiang

Assistant Professor
Harvard Medical School & Beth Israel Deaconess Medical Center

J. Carl Barrett

CSA
Independent Expert

David Ting

Co-Director & Director - Biomarker Discovery Lab & Tumor Cartography Center, Clinical Innovation
Mass General Brigham Cancer Institute & Harvard Medical School

Michael Berger

Co-Director, Marie Josee & Henry Kravis Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center

Mark Ewalt

Associate Attending
Memorial Sloan Kettering Cancer Center (on behalf of Pillar Biosciences)

Lee Cooper

Professor & Director, Computational Division, Department of Pathology
Northwestern University

Eve Stoddard

Patient Advocate
Participating on behalf of Roche

Haley Director

Board of Directors, Policy
Rare New England

Tasia Rechisky

Board of Directory, Secretary, Policy Co-Lead, Rare Disease Patient & Advocate
Rare New England

Jill Weimer

Senior Director, Therapeutic Development
Sanford Research

Jim Palma

Chief Executive Officer
TargetCancer Foundation

Marshall Thompson

Chief Technology Officer
The Rare Cancer Research Foundation

Matthew G.Hanna

Vice Chair, Pathology Informatics
University of Pittsburgh Medical Center

Biotech Pioneers

Chloe Delepine

Director, Clinical Biomarkers
Agenus

Glen Weiss

Chief Medical Officer
Bantam Pharmaceutical

Priya S. Chockalingam

Vice President & Head, Clinical Bioanalytics & Translational Sciences
Beam Therapeutics

Hannah Majeski

Principal Scientist, Biology
BioTheryx

Francesca Barone

Chief Scientific Officer
Candel Therapeutics

Kris Sachsenmeier

Vice President, Translational Sciences
Compass Therapeutics

Heather Cohen

Vice President, Precision Medicine & Biomarkers
CREATE Medicines

Jarema Kochan

Senior Director, Clinical Biomarkers, Clinical Development
Eikon Therapeutics

Kathryn Newhall

Executive Director, Translational Biomarkers & Diagnostics
Immunome

John Goldberg

Acting Chief Development Officer
Incendia Therapeutics

Erin Crowgey

Director, Translational Medicine
Incyte

Robin Edwards

Vice President, Translational Medicine
MacroGenics

Sydney Hart

Senior Scientist
Merck & Co

Marla Weetall

Senior Vice President, Pharmacology & Biomarkers
PTC Therapeutics

Marsha Crochiere

Vice President, Translational Medicine & Research
Pyxis Oncology

Travis Wager

Co-Founder, President & Chief Scientific Officer
Rgenta Therapeutics

Scott Yohe

Senior Vice President, Managed Markets & Access Strategy
Rigel Pharmaceutical

Amy Wehn

Executive Director & Head, Companion Diagnostics & Clinical Biomarkers
Tango Therapeutics

Marie Du

Executive Director, Biomarker & Translational Operations
Vanqua Bio

Leading Precision Medicine Solution Providers

Fran Mullen

Associate Director, Business Development, Companion Diagnostics
Abbott Laboratories

Bryant Wojcik

Program Manager
Abbott Laboratories

Jeffrey Wuitschick

Director, R&D
Abbott Molecular

Zhen Mahoney

Director, Companion Diagnostics Business Development
Agilent Technologies

Alyssa Tarzia

Companion Diagnostics Principal Regulatory Scientist
Agilent Technologies

Karina Kulangara

Associate Vice President, Companion Diagnostics R&D
Agilent Technologies

Stewart McWilliams

Global Vice President, Quality & Regulatory Affairs
Almac Diagnostic Services

James Lappin

Director, Corporate affairs
ARC Regulatory

Jill Walker

Founder & Chief Executive Officer
Beacon Scientific Consulting

Colin McDowell

Senior Manager, Business Development
Biodesix

Jean-Philippe Vert

Chief Executive Officer
Bioptimus

Amy Williams

Global Head of Clinical Development, Medical Affairs, & Clinical Operations
Biovica

Michael Chen

Senior Translational Medicine Scientist
Burning Rock Dx

Carla Kantara

Vice President & Head, Enterprise Partnering, Global Biopharma Business Development
Caris Life Sciences

Milan Radovich

Chief Scientific Officer & Head, Business Development
Caris Life Sciences

Christopher Ung

Scientific Business Chief & Officer
CellCarta Inc

Gulfem Guler

Vice President, Translational Research
ClearNote Health

T. Scott Reid

Vice President & Global Head of Companion Diagnostics
Discovery Life Sciences

Staci J Kearney

Founder & Chief Executive Officer
Elevation Strategic Development

Matthew Maland

Director, Regulatory Affairs
EntroGen

Maria Szwarc

Scientist II
Flagship Biosciences

David Fabrizio

Vice President, Commercial Strategy & Medical Innovation
Foundation Medicine

Varun Pattani

Senior Director & Head, Diagnostic Development
Foundation Medicine

Jay Foust

Head, External Engagement, Precision Diagnostics
GlaxoSmithKline

Eric Fung

Chief Medical Officer
GRAIL

Justin Odegaard

Senior Vice President, Product
Guardant Health

Julie Ramage

Principal
Harbor Precision Genomics Consulting

Naveen Babbar

Vice President, Precision Medicine & Biomarker Services
ICON

Ali Kuraishy

Senior Director & Head, Clinical Business Development
Illumina

Brian Laffin

Vice President, Translational & Clinical Strategy
Imagene AI

Devin Craven

Senior Director, Regulatory Affairs Companion Diagnostics
LabCorp

Alan Arnold

Scientific Senior Director, Precision Medicine, Diagnostic Development Services
LabCorp

Shanshan Zhou

Director, Companion Diagnostics Development
LabCorp

Siraj Ali

Global Vice President, Translation Medicine
Lunit

Patrick Frey

Vice President, Precision Medicine
MindPeak GmbH

Zivjena Vucetic

Chief Medical Officer
Mission Bio

Dale Muzzey PhD

Chief Scientific Officer
Myriad Genetics

Reny Aniline

Senior Director, BioPharma Business Development
Natera

John Simmons

Global Vice President, Biopharma & Oncology Partnerships
Natera

Christine Federovitch

Head, Regulatory Affairs, IVD
Navigate BioPharma

Grainger Greene

Head, Product
Nucleai

Hedi Ben Brahim

Chief Executive Officer
One Biosciences

Hasan Djenan

Director, Commercial & Clinical Sales
Panakeia Technologies

Ben Glass

Senior Vice President, Product, Research & AI
PathAI

Pierre Moulin

Chief Scientific Officer
Patholytix

Alexander Kuklin

Vice President, Biopharma Partnerships
Predicine

Assaf Kacen

Co-Founder & Chief Technology Officer
Promise Bio

Greg Baschkopf

Executive Director, IVD & CDx
Quest

Tracy Davis

Pathologist
Roche

Matt Nelson

Chief Executive Officer
SentryDx

Matthew Alderdice

Senior Vice President, Product
Sonrai Analytics

Julien Pontis

Head, Companion Diagnostics & Clinical Diagnostics
SOPHiA GENETICS

Kate Sasser

Chief Scientific Officer
Tempus

Evan McMenamy

Staff Program Manager
Thermo Fisher Scientific Inc

Scott Myrand

Director, Diagnostic Partnering
Thermo Fisher Scientific Inc

Scott Fogerty

Director
Thermo Fisher Scientific Inc

Chelsea Pfaff

Senior Manager, Regulatory Affairs
Thermo Fisher Scientific Inc
Mark Roberts - Expert Speaker

Mark Roberts

Chief Operating Officer
Versiti Clinical Trial Solutions

Scott Bornheimer

Director, Medical Affairs & CDx
Waters Biosciences

Sifan Zhang

Manager
ZS
2
Explore the New Agenda

Hear the latest imaging, multi-omics, single-cell and functional assays, enhanced by AI-driven digital biomarker strategies, enabling earlier and smarter treatment decisions for oncology, autoimmune, neurological, chronic and rare disease patients

View 2026 Presentations & Speakers
CDx Europe - Networking Page
Partner with Us

Position your solutions alongside leading biomarker, diagnostic and technology providers, to ensure your brand is front and center, and retain your place as the partner of choice in the ever-expanding precision medicine space

View Partnership Options
1
Join 850+ Specialist Experts

Be part of the liveliest Rx-Dx conversations with like-minded industry peers spanning a range of precision therapy modalities, and build high-value connections during dedicated networking sessions designed to foster collaborations

Register Interest